Stock data

益安 (6499)

益安 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$231.52M, up 513.1% from a year earlier. EPS over the last four quarters totals -NT$5.92.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 益安 in Insightr